[Diuretic therapy in cardiac insufficiency].
D001581:Benzothiadiazines; D004232:Diuretics / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004347:Drug Interactions; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000187:drug effects; D049993:Sodium Chloride Symporter Inhibitors / Q000494:pharmacology; D013148:Spironolactone / Q000494:pharmacology; D013449:Sulfonamides
D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D013449:Sulfonamides; D013148:Spironolactone
Diuretikatherapie der Herzinsuffizienz.